VentriPoint Diagnostics Showcases AI Cardiac Imaging Platform at AEPC 2026

VentriPoint Diagnostics will present its AI-powered cardiac imaging system at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology (AEPC), running May 12 to 16 in Padua, Italy, announced in a press release. The company will exhibit alongside European distributor AngioPro at the event, which focuses on cardiovascular imaging and artificial intelligence.

The VMS+ 4.0 platform converts standard two dimensional ultrasound scans into detailed three dimensional heart models. VentriPoint states that the system delivers results comparable to cardiac MRI while using standard ultrasound equipment. The technology is based on more than a decade of proprietary Knowledge Based Reconstruction research and holds approvals in the United States, Canada, and Europe.

VentriPoint’s regulatory expansion continues, with its strategic partner Lishman Global submitting VMS+ 4.0 to China’s National Medical Products Administration for review under the expedited green channel pathway. The company also reports new commercial partnerships in Costa Rica, Canada, and Northern California, along with a recent Gold Medal win at the 2026 Edison Awards.

These developments mark continued momentum as VentriPoint builds a wider global footprint for its cardiac imaging technology across multiple healthcare markets.